5.4 CLSI Order of Draw & Tube Additive Mechanics

5.4 CLSI Order of Draw & Tube Additive Mechanics

Clinical Core: The multisample venipuncture needle penetrates the rubber stoppers of multiple collection tubes sequentially. When an evacuated tube fills, blood and tube additives coat the internal piercing pin. If tubes are drawn out of sequence, chemical additives from one tube transfer into subsequent tubes (additive carryover), causing severe pre-analytical biochemical distortions that compromise medical diagnoses. The CLSI GP41 Order of Draw is the universally mandated protocol to eliminate additive cross-contamination.

---

The CLSI GP41 Order of Draw Sequence

Every diagnostic venipuncture utilizing evacuated tube systems (ETS) or multi-tube syringe transfers must follow the strict sequence established by the Clinical and Laboratory Standards Institute:

+=============================================================================+
|                    CLSI GP41 EVACUATED TUBE ORDER OF DRAW                   |
+=============================================================================+
| 1. BLOOD CULTURES / SPS       | Yellow / Broth Bottles | Aerobic -> Anaerob |
| 2. COAGULATION                | Light Blue             | 3.2% Sodium Citrate|
| 3. SERUM TUBES (Glass/Plastic)| Red, Gold, Tiger SST   | Clot Activator/Gel |
| 4. HEPARIN (PST / Rapid Chem) | Green, Light Green PST | Lithium/Na Heparin |
| 5. EDTA (Hematology/Immuno)   | Lavender, Purple, Pink | K2 / K3 EDTA       |
| 6. GLYCOLYTIC INHIBITOR       | Gray                   | Na Fluoride/Oxalate|
+=============================================================================+

[!IMPORTANT] Royal blue trace-element tubes are not a seventh position in GP41. CLSI GP41 defines the six positions above. A royal blue tube is manufactured with EDTA, heparin, or no additive, and it is drawn at the position matching its own additive — a royal blue EDTA tube goes where lavender goes, and a royal blue no-additive tube goes with the serum tubes. Many teaching charts show it last, which works in practice when a single trace-element tube is drawn, but it is not what the standard specifies. If an item asks what GP41 defines, the answer is the six-tube sequence.

---

Detailed Analysis of Tube Additives and Biochemical Mechanisms

1. Blood Cultures (SPS / Blood Culture Bottles)

• Stopper / Bottle Types: Aerobic bottle (blue/green), Anaerobic bottle (orange/purple), Pediatric bottle (yellow/pink), or Yellow-top glass tube containing Sodium Polyanethol Sulfonate (SPS).
• Mechanism of Action: SPS acts as an anticoagulant by binding ionized calcium ($Ca^{2+}$). Critically, SPS inhibits complement activity, neutralizes human bactericidal lysozymes, and inactivates aminoglycoside and polypeptide antibiotics in the patient's blood, allowing micro-organisms to proliferate in liquid nutrient media.
• Specimen Type: Whole blood in enriched broth.
• Inversion Count: 8 to 10 gentle inversions.
• Common Tests: Blood Cultures for suspected bacteremia, sepsis, infective endocarditis, and fever of unknown origin (FUO).
• Why Drawn First: Blood culture bottles require absolute sterility. Drawing them first eliminates skin flora or chemical contamination from non-sterile tube stoppers, needle holders, or clot activators that would otherwise suppress microbial growth or yield false-positive cultures.

2. Coagulation Tube (Light Blue - 3.2% Sodium Citrate)

• Additive: Buffered 3.2% (0.109 M) Sodium Citrate.
• Mechanism of Action: Binds and chelates ionized calcium ($Ca^{2+}$), halting the coagulation cascade at extrinsic, intrinsic, and common pathway checkpoints.
• Specimen Type: Citrated Plasma.
• Inversion Count: 3 to 4 gentle inversions (avoid excessive mixing, which mechanically activates platelets and factor VIII).
• Common Tests: Prothrombin Time (PT / INR), Activated Partial Thromboplastin Time (aPTT), Fibrinogen, D-Dimer, Factor Assays, Thrombin Time (TT).
• The Critical 9:1 Ratio: Light blue tubes require an exact 9:1 blood-to-anticoagulant ratio (9 parts whole blood to 1 part liquid citrate). A standard 4.5 mL draw tube contains exactly 0.5 mL of liquid citrate. Underfilling the tube (<90% of target fill volume) leaves excess free citrate in the specimen, which binds the calcium reagent during laboratory testing and causes falsely prolonged PT/INR and aPTT results. Overfilling (>10% excess blood) depletes anticoagulant, causing micro-clot formation and falsely shortened coagulation times.
• Why Drawn Second: Must precede serum tubes (which contain silica clot activators) and heparin tubes (which contain powerful thrombin inhibitors). Silica carryover triggers premature clotting factor consumption, while heparin carryover profoundly prolongs aPTT and PT.

3. Serum Tubes (Red Glass, Red Plastic Clot Activator, Gold/Tiger SST)

• Additives:
  • Plain Red Glass: No additive; the silica in glass naturally activates Factor XII (Hageman factor) via surface contact.
  • Plastic Red: Spray-coated micronized silica particles (clot activators).
  • Gold Top / Tiger (Mottled Red/Gray) SST: Silica clot activator plus an inert thixotropic polyester polymer gel barrier.
• Mechanism of Action: Silica particles accelerate the intrinsic clotting cascade, completing full clot formation within 30 to 60 minutes. During centrifugation (1,000 to 2,000 g for 10 to 15 minutes), the polymer gel's intermediate density (1.04 g/cm³) causes it to migrate between the dense packed red cells (1.09 g/cm³) and the lighter liquid serum (1.028 g/cm³), forming a physical barrier that stops cellular metabolism from altering serum analytes.
• Specimen Type: Serum (the liquid portion of clotted blood; lacks fibrinogen and clotting factors II, V, and VIII, which were consumed in clot formation).
• Inversion Count: Plastic Red = 5 inversions; Gold/Tiger SST = 5 inversions; Glass Red = 0 inversions.
• Common Tests: Comprehensive Metabolic Panel (CMP), Basic Metabolic Panel (BMP), Lipid Panel, Hepatic Function, Renal Function, Cardiac Enzymes, Serology, Therapeutic Drug Monitoring (plain red without gel).
• Why Drawn Third: Placed after citrate to prevent silica particles from accelerating coagulation tests, and before heparin/EDTA to prevent anticoagulant contamination of clinical chemistry assays.

4. Heparin Tubes (Green, Light Green PST, Dark Green)

• Additives:
  • Light Green PST (Plasma Separator Tube): Lithium Heparin with thixotropic gel barrier.
  • Dark Green: Sodium Heparin or Lithium Heparin (without gel).
• Mechanism of Action: Heparin enhances the activity of antithrombin III (AT-III) by several hundred-fold, rapidly inactivating thrombin and Factor Xa and preventing fibrinogen from converting into fibrin.
• Specimen Type: Plasma (liquid portion of unclotted blood; contains fibrinogen).
• Inversion Count: 8 to 10 gentle inversions.
• Common Tests: STAT Chemistry panels (Troponin, Potassium, Electrolytes, Renal Panel), Ammonia (on wet ice slurry), Arterial/Venous Blood Gases.
• Clinical Advantage: PST tubes eliminate the 30-to-60 minute clotting wait time required for serum tubes. Blood can be centrifuged immediately upon arrival in the laboratory, saving vital minutes during cardiac or stroke emergencies.
• Additive Nuance: Lithium heparin cannot be used for serum lithium drug monitoring (causes massive false lithium toxicity). Sodium heparin cannot be used for electrolyte sodium measurements or cytogenetic studies requiring non-sodium bases.

5. EDTA Tubes (Lavender, Purple, Pink, Pearl PPT)

• Additives: Spray-coated Dipotassium EDTA ($K_2 ext{EDTA}$), liquid Tripotassium EDTA ($K_3 ext{EDTA}$), or Disodium EDTA ($Na_2 ext{EDTA}$). Pink tops contain $K_2 ext{EDTA}$ with specialized blood bank patient crossmatch labels. Pearl PPT tubes contain $K_2 ext{EDTA}$ with a polymer gel.
• Mechanism of Action: Potent chelator of divalent metal cations, specifically binding ionized calcium ($Ca^{2+}$) into insoluble complexes. EDTA provides unmatched preservation of erythrocyte cellular morphology, leukocyte staining characteristics, and complete prevention of in vitro platelet clumping.
• Specimen Type: Whole Blood (Hematology) or Plasma (PPT Viral Load testing).
• Inversion Count: 8 to 10 gentle inversions.
• Common Tests: Complete Blood Count (CBC with automated Differential), Hemoglobin & Hematocrit (H&H), Erythrocyte Sedimentation Rate (ESR), Hemoglobin A1c (HbA1c), Blood Bank ABO/Rh Typing and Crossmatching (Pink top), Molecular Viral Load Testing (HIV/HCV PCR).
• The Severe Carryover Danger: If an EDTA tube is drawn before a serum or heparin chemistry tube, tiny droplets of $K_2 ext{EDTA}$ aerosolize or coat the multisample needle and contaminate the subsequent tube. This produces two lethal clinical errors:
  1. Artifactual Hyperkalemia: The potassium additive from $K_2 ext{EDTA}$ artificially spikes measured serum/plasma potassium (e.g., jumping from 4.0 mEq/L to >8.0 mEq/L).
  2. Artifactual Hypocalcemia: The EDTA binds and chelates the patient's serum calcium, dropping measured calcium to near zero (e.g., <3.0 mg/dL). This false "hyperkalemia + hypocalcemia" profile can trigger inappropriate emergency interventions (e.g., hemodialysis or calcium gluconate boluses).

6. Glycolytic Inhibitor Tubes (Gray Top)

• Additives: Sodium Fluoride combined with an anticoagulant (Potassium Oxalate).
• Mechanism of Action: Sodium fluoride acts as an antiglycolytic agent by poisoning the enzyme enolase in the cellular glycolytic pathway. Normal uninhibited red blood cells consume glucose at a rate of 5% to 7% per hour at room temperature. Sodium fluoride arrests glycolysis completely, preserving true in vivo glucose concentrations for up to 72 hours (3 days). Potassium oxalate binds calcium to prevent clotting.
• Specimen Type: Fluoride Plasma or Whole Blood.
• Inversion Count: 8 to 10 gentle inversions.
• Common Tests: Fasting Blood Glucose (FBG), Oral Glucose Tolerance Tests (OGTT), Legal Blood Alcohol / Ethanol levels (sodium fluoride inhibits ethanol metabolism by yeast/bacteria), Plasma Lactic Acid (on wet ice).
• Why Drawn Sixth: Sodium fluoride and potassium oxalate cause severe red blood cell membrane lysis, destroy leukocyte morphology, and distort enzyme assays. Drawing gray tubes early invalidates all subsequent hematology and chemistry panels.

7. Trace Element / Special Tubes (Royal Blue Top)

• Characteristics: Specially manufactured with ultra-low trace element background (<0.01 mcg/tube for heavy metals). Tubes have color-coded label stripes indicating additive: Red stripe (Plain / Clot Activator), Lavender stripe ($K_2 ext{EDTA}$), or Green stripe (Sodium Heparin).
• Common Tests: Serum/whole blood toxicology for Lead, Arsenic, Mercury, Cadmium, Copper, Zinc, Chromium, Aluminum.
• Order Placement: Drawn in the sequence corresponding to its specific internal additive (e.g., royal blue with EDTA follows green heparin and precedes gray; royal blue plain follows citrate and precedes heparin), or collected first with a dedicated separate needle to eliminate all environmental metal transfer.

---